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Abstract
Background: prevention of disability is an important aim of healthcare for older persons. Selection of persons at risk is a
ﬁrst crucial step in this process.
Objectives: this study investigates the predictive value of multimorbidity for the development of disability in the general
population of very old people and the role of cognitive impairment in this association.
Design: the Leiden 85-plus Study (1997–2004) is an observational prospective cohort study with 5 years of follow-up.
Setting: general population of the city of Leiden, the Netherlands.
Subjects: population based sample of 594 participants aged 85 years.
Methods: disability in activities of daily living (ADL) was measured annually for 5 years with the Groningen Activity
Restriction Scale (range 9–36, 9=optimal). Multimorbidity is deﬁned as the presence of two or more chronic diseases at
age 85 years. Cognitive function was measured at baseline with the mini-mental state examination (MMSE).
Results: at baseline participants with multimorbidity had higher ADL disability scores compared with those
without [median 11 inter-quartile range (IQR 9–16) versus 9 (IQR 9–13) ADL points, Mann–Whitney U test P<0.001].
Stratiﬁed into four MMSE groups, ADL disability increased over time in all groups, even in participants without
multimorbidity (P trend <0.001). Multimorbidity predicted accelerated increase in ADL disability in participants with
MMSE of 28–30 points (n=205, 0.67 points/year, P<0.001), but not in participants with lower MMSE scores (all P>
0.100).
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Y. M. Drewes et al.Conclusion: the predictive value of multimorbidity for the increase in ADL disability varies with cognitive function in very
old people. In very old people with good cognitive function, multimorbidity predicts accelerated increase in ADL disability.
This relation is absent in very old people with cognitive impairment.
Keywords: disability, multimorbidity, cognitive impairment, prediction, elderly
Introduction
The aim of preventive programmes for older people is to
enable them to live as independently as possible for as long
as possible. For these programmes instruments are needed
to identify older people at high risk to develop disability in
the near future. When such instruments are available, older
people can pro-actively be approached to prevent increase
in disability.
It is known that chronic diseases [1–7]and multimorbid-
ity [6–8] are strongly related with disability. However, most
of these studies incorporated cognitive impairment or
dementia in their multimorbidity scores. Because earlier
studies showed strong associations between cognitive func-
tion and disability [2–4, 6–13], the predictive value of multi-
morbidity for disability may differ between persons with
and without cognitive impairment.
Therefore, we studied the predictive value of multimor-
bidity for the increase in disability in activities of daily
living (ADL) in older persons with and without cognitive
impairment.
Methods
Setting and study population
The Leiden 85-plus Study is an observational population-
based prospective follow-up study of 85-year-old inhabi-
tants of Leiden (the Netherlands). Between September
1997 and September 1999, all inhabitants of Leiden who
reached the age of 85 years were invited to participate in
the study.
Participants were followed for 5 years until the age of
90 years or until death. Date of death was obtained from
the municipality. All participants were visited annually at
their place of residence where face-to-face interviews were
conducted, cognitive testing was performed, and disabilities
in basic ADL were measured.
All participants gave their informed consent; for
those with severe cognitive impairment, informed
consent was obtained from a proxy. The Medical Ethics
Committee of Leiden University Medical Centre approved
the study.
For the present study, participants with missing ADL
measurements at baseline and participants with missing
information on the presence of two or more chronic dis-
eases at baseline were excluded.
Main study parameters
Determinants
Information on the presence of chronic diseases at baseline
was obtained from the participant’s general practitioner
(GP), nursing home physician and/or pharmacy records.
We included common chronic diseases in the analyses,
which are commonly used in multimorbidity scores [14,
15]: arthritis, chronic obstructive pulmonary disease
(COPD), diabetes mellitus, heart failure, stroke, Parkinson
disease, depressive symptoms reported in the previous year,
and history of cancer or myocardial infarction. COPD was
considered present when lung medication [Anatomical
Therapeutic Chemical (ATC) code R03] was used at age 85
years. Multimorbidity was deﬁned as the presence of two
or more of the nine chronic diseases investigated.
Cognitive function was assessed with the mini-mental
state examination (MMSE), with scores ranging from 0 to
30 (=optimal function) [16] and was stratiﬁed in four
groups: MMSE score <19 points (severe cognitive impair-
ment), 19–23 points (moderate cognitive impairment), 24–
27 points (mild cognitive impairment) and 28–30 points
(optimal cognitive function).
Outcome
Disability in basic ADL was determined with the Groningen
Activity Restriction Scale, which assesses an individual’s
competence in the following nine basic activities: walk
inside, get up out of bed, get into and out of a chair, visit
the toilet, wash hands and face, wash body, dress and
undress, eat and drink and make breakfast [17, 18].
Questions are phrased: “Can you, fully independently,…?”.
Answers range from “Fully independently, without any difﬁculty”
(1 point) to “Not fully independently, only with someone’s help” (4
points). The total ADL disability score ranges from 9 to 36.
Data analysis
In the cross-sectional analysis, median scores of ADL dis-
ability at age 85 years between participants were compared
using the Mann–Whitney U test.
Prospectively, the relation between individual chronic
diseases and multimorbidity at baseline and changes in
ADL-disability scores over time were analysed with linear
mixed models. Each linear mixed model included the indi-
vidual disease a term for time, and a term for the inter-
action between disease and time. The results of the linear
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Disability, cognition and multimorbiditymixed models are as follows: the effect of time on disability
in ADL reﬂects the annual change in ADL disability in
those without the disease, and is presented as basic annual
change in ADL disability score. The interaction of an indi-
vidual chronic disease and time reﬂects the additional
annual change in ADL disability for those with the disease
and is presented as additional annual change in ADL dis-
ability score.
To assess the inﬂuence of cognitive impairment, partici-
pants were stratiﬁed into four groups according to their base-
line MMSE score (0–18, 19–23, 24–27 and 28–30) [19]a n d
the predictive effect of multimorbidity on changes in disabil-
ity in ADL were examined separately in these four groups.
Data were analysed using SPSS 16.0 (Chicago, IL, USA).
Results
Study population
Between September 1997 and September 1999, 705 inhabi-
tants of Leiden reached the age of 85 years and were eli-
gible for participation in the study. A total of 14 persons
died before enrolment in the study, 92 declined to partici-
pate, no ADL measures were available for two persons,
and for three persons information on the presence of two
or more chronic diseases was missing. Therefore baseline
data were available for 594 participants. Appendix 1,
Supplementary data are available in Age and Ageing online,
shows the numbers of participants at the start of the study
and annually over the 5-year follow-up period.
Cross-sectional analysis
Table 1 presents the baseline characteristics, the prevalence
of the investigated chronic diseases, and the prevalence of
multimorbidity among the participants at age 85 years. In
total, 34% of the participants were male. The prevalence of
multimorbidity was 39%. Arthritis was the most common
chronic disease (33%).
At baseline, participants with arthritis, depressive symp-
toms, diabetes mellitus, stroke and Parkinson disease had
higher scores of ADL disability than participants without
these diseases (Supplementary data are available in Age and
Ageing online, Appendix 2). The greatest differences in
median ADL disability scores between participants with and
without an individual chronic disease were seen for Parkinson
disease (19 versus 10 points, P<0.001) and stroke (15 versus
10 points, P<0.001). Participants with multimorbidity had
higher ADL disability scores compared with those without
multimorbidity (11 versus 9 points, P<0. 001) .
At baseline, highest ADL disability scores were found in
participants with an MMSE score <19 (Figure 1). In the
groups with MMSE scores of 19–23, 24–27 and 28–30,
higher baseline ADL disability scores were found for par-
ticipants with multimorbidity than for participants without
multimorbidity (all P≤0.010). However, in subjects with an
MMSE score <19, no differences in ADL disability scores
were found between participants with multimorbidity and
those without multimorbidity (median ADL disability
scores: 19 versus 19 points, P=0.950).
Prospective analyses
Appendix 3, Supplementary data are available in Age and
Ageing online, presents the relation of individual chronic dis-
eases and multimorbidity with additional annual changes in
ADL performance. In participants without any of the
investigated chronic diseases, the basic annual change in
ADL disability score was 1.2 points per year (95% CI 1.0–
1.4, P<0.001, data not shown). Depressive symptoms,
heart failure, myocardial infarction and stroke predicted an
additional annual change in ADL disability score during
follow-up. Other individual chronic diseases did not predict
an additional annual change in ADL disability score (all P
>0.100). Participants with multimorbidity had an acceler-
ated progression of ADL disability over time compared
with those without multimorbidity: additional annual
change 0.42 points (95% CI 0.21–0.63, P<0.001).
The effect of cognitive function on the predictive value
of multimorbidity for disability in ADL was investigated by
stratifying the participants into four groups according to
their MMSE scores at baseline (Figure 2, Supplementary
data are available in Age and Ageing online, Appendix 4). In
all MMSE groups, ADL disability increased over time,
independent of the presence of multimorbidity (basic
annual change, P for trend <0.001).
Multimorbidity was associated with an additional annual
change in ADL disability of 0.67 points (95% CI 0.39–
........................................
Table 1. Baseline characteristics of the study population at
age 85 years (n=594
a)
n %
Sociodemographic characteristics
Sex, male 201 34
Low level of education—primary school only 383 65
Prevalence of individual chronic diseases
Arthritis 193 33
Depressive symptoms 125 21
History of cancer 104 18
Diabetes mellitus 86 15
Heart failure 75 13
COPD 70 12
Myocardial infarction 63 11
Stroke 61 10
Parkinson disease 15 2.5
Total number of chronic diseases
None 147 25
One 213 36
Two or more (multimorbidity) 234 39
Classification in the mini-mental state examination (MMSE)
MMSE <19 patients 97 16
MMSE 19–23 patients 85 14
MMSE 24–27 patients 207 35
MMSE 28–30 205 35
aMissing data in n=0 ton= 11 per disease; of 568 participants the data on
chronic diseases were complete. COPD, chronic obstructive pulmonary
disease.
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Y. M. Drewes et al.Figure 1. ADL disability scores dependent on the presence of multimorbidity at age 85 years stratiﬁed for cognitive function.
Data were presented as medians and corresponding inter-quartile ranges, P-values estimated with the Mann–Whitney U test;
ADL, activities of daily living; MMSE, mini-mental state examination.
Figure 2. Changes in ADL-disability points over time depending on multimorbidity in participants from age 85 years onwards,
for strata of cognitive function. ADL, activities of daily living; MMSE, mini-mental state examination.
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Disability, cognition and multimorbidity0.95, P<0.001) in subjects with an MMSE score of 28–30.
In participants with an MMSE score <28, multimorbidity
did not predict the change in ADL disability (additional
annual change, P for trend <0.001).
Comment
Principal findings
This population-based study of very old people demon-
strates that disability in ADL increases over time in older
persons of the general population. Multimorbidity only pre-
dicted accelerated increase in disability in ADL in older
people with an optimal cognitive function (MMSE score
≥28 points). In persons with lower MMSE scores, this
relation was not observed.
Our ﬁndings are in agreement with earlier studies
showing that both cognitive impairment and multimorbidity
are associated with the development of disability in ADL in
older persons [9–11, 13, 15, 20]. However, these studies did
not report that this relation is only present in older people
with MMSE scores ≥28 points. A possible explanation for
these ﬁndings is that the effect of cognitive impairment on
ADL performance overwhelms the effect of multimorbid-
ity. Another possible explanation is the possibility that cog-
nitive performance at the age of 85 years is a marker for
the total health condition, with a high sensitivity to detect
detrimental effects on ADL disability. In persons with cog-
nitive impairment, we found large basic annual changes in
ADL disability score, indicating that in persons with cogni-
tive impairment ADL disability increases, independent of
the presence of multimorbidity.
Strength and limitations
Our study has several strengths. The population-based
setting and almost complete follow-up of the participants
allow to generalise the conclusions to older people (aged 85
years and over) in the general population. It is important to
study the development of disability in ADL in old age,
because the very old are the fastest growing segment of the
general population [21] and the prevalence of disability in
ADL increases with age [12, 22, 23]. Therefore, disability in
ADL in old age can have a signiﬁcant effect on
quality-of-life, healthcare needs and costs in our ageing
society. Furthermore, the study stratiﬁed on cognitive func-
tion, allowing to investigate the predictive value of multi-
morbidity for disability in ADL at different levels of
cognitive function.
A possible limitation of the present study is that we
used a selection of only nine diseases, as diagnosed by
physicians. The prevalence of multimorbidity might have
been different when other chronic diseases had been
included, or when more speciﬁc diagnostic tests had been
used. In addition, we did not take the severity of the
chronic diseases into account. However, our approach of
multimorbidity, by using only data of the GPs, nursing
home physicians and pharmacy records, reﬂects clinical
practice and similar systems of adding individual diseases
have been applied in many other studies [8].
Clinical implications and future research
The most important clinical implication is that multimor-
bidity can only be used as a predictor for disability in ADL
in older people with optimal cognitive function. Older
people with an MMSE score less than 28 are at the highest
risk for disability in ADL. However, multimorbidity is no
longer an additional predictor of disability in ADL in this
group. Preventive programmes to promote older people to
live as independently as possible may use a two-stage
screening test, which contains MMSE screening as a ﬁrst
step and multimorbidity screening as the second, to select
older people at risk for disability.
Key points
￿ The predictive value of multimorbidity for the increase
in disability in ADL varies with cognitive function.
￿ Multimorbidity does not predict accelerated increase in
disability in ADL in older persons with cognitive
impairment.
￿ Only in older persons with good cognitive function,
multimorbidity predicts accelerated increase in disability
in ADL.
￿ For selection of high-risk patients, multimorbidity can be
used only in those older persons without cognitive
impairment.
Author contributions
Gussekloo had full access to all of the data in the study
and takes responsibility for the integrity of the data and the
accuracy of the data analysis.
Studyconcept and design: de Craen and Gussekloo.
Acquisition of data: de Craen and Gussekloo.
Analysis and interpretation of data: Drewes, den Elzen, de
Craen, Mooijaart, Assendelft and Gussekloo.
Drafting of the manuscript: Drewes and den Elzen.
Critical revision of the manuscript for important intellectual
content: Drewes, den Elzen, de Craen, Mooijaart, Assendelft
and Gussekloo.
Obtained funding: Gussekloo.
Conflicts of interest
None declared.
356
Y. M. Drewes et al.Funding
The Leiden 85-plus Study was partly funded by an unrest-
ricted grant from the Dutch Ministry of Health, Welfare
and Sports. The funder played no role in study design, col-
lection, analysis and interpretation of data, writing of the
report, and in the decision to submit the article for
publication.
Ethical approval
The medical ethical committee of Leiden University
Medical Center approved the study in 1997.
Independence of researchers
All researchers were independent from the funder.
Supplementary data
Supplementary data mentioned in the text is available to
subscribers in Age and Ageing online.
References
1. Puts MT, Deeg DJ, Hoeymans N, Nusselder WJ, Schellevis
FG. Changes in the prevalence of chronic disease and the
association with disability in the older Dutch population
between 1987 and 2001. Age Ageing 2008; 37: 187–93.
2. Spiers NA, Matthews RJ, Jagger C et al Diseases and impair-
ments as risk factors for onset of disability in the older popu-
lation in England and Wales: ﬁndings from the Medical
Research Council Cognitive Function and Ageing Study. J
Gerontol A Biol Sci Med Sci 2005; 60: 248–54.
3. Reynolds SL, Silverstein M. Observing the onset of disability
in older adults. Soc Sci Med 2003; 57: 1875–89.
4. Tas U, Verhagen AP, Bierma-Zeinstra SM et al Incidence and
risk factors of disability in the elderly: the Rotterdam Study.
Prev Med 2007; 44: 272–8.
5. Wang L, van Belle G, Kukull WB, Larson EB. Predictors of
functional change: a longitudinal study of nondemented
people aged 65 and older. J Am Geriatr Soc 2002; 50:
1525–34.
6. Cigolle CT, Langa KM, Kabeto MU, Tian Z, Blaum CS.
Geriatric conditions and disability: the Health and Retirement
Study. Ann Intern Med 2007; 147: 156–64.
7. Kriegsman DM, Deeg DJ, Stalman WA. Comorbidity of
somatic chronic diseases and decline in physical functioning:
the Longitudinal Aging Study Amsterdam. J Clin Epidemiol
2004; 57: 55–65.
8. Stuck AE, Walthert JM, Nikolaus T, Bula CJ, Hohmann C,
Beck JC. Risk factors for functional status decline in
community-living elderly people: a systematic literature review.
Soc Sci Med 1999; 48: 445–69.
9. Njegovan V, Hing MM, Mitchell SL, Molnar FJ. The hierarchy
of functional loss associated with cognitive decline in older
persons. J Gerontol A Biol Sci Med Sci 2001; 56: M638–43.
10. Greiner PA, Snowdon DA, Schmitt FA. The loss of indepen-
dence in activities of daily living: the role of low normal cognitive
function in elderly nuns. Am J Public Health 1996; 86: 62–6.
11. Raji MA, Ostir GV, Markides KS, Goodwin JS. The inter-
action of cognitive and emotional status on subsequent phys-
ical functioning in older mexican americans: ﬁndings from
the Hispanic established population for the epidemiologic
study of the elderly. J Gerontol A Biol Sci Med Sci 2002; 57:
M678–82.
12. Tas U, Verhagen AP, Bierma-Zeinstra SM, Odding E, Koes
BW. Prognostic factors of disability in older people: a sys-
tematic review. Br J Gen Pract 2007; 57: 319–23.
13. Orsitto G, Cascavilla L, Franceschi M et al Inﬂuence of cog-
nitive impairment and comorbidity on disability in hospital-
ized elderly patients. J Nutr Health Aging 2005; 9: 194–8.
14. Bootsma-van der Wiel A, Gussekloo J, De Craen AJ, Van
Exel E, Bloem BR, Westendorp RG. Common chronic dis-
eases and general impairments as determinants of walking
disability in the oldest-old population. J Am Geriatr Soc
2002; 50: 1405–10.
15. Marengoni A, von Strauss E, Rizzuto D, Winblad B, Fratiglioni
L. The impact of chronic multimorbidity and disability on func-
tional decline and survival in elderly persons. A community-
based, longitudinal study. J Intern Med 2009; 265: 288–95.
16. Heeren TJ, Lagaay AM, von Beek WC, Rooymans HG,
Hijmans W. Reference values for the Mini-Mental State
Examination (MMSE) in octo- and nonagenarians. J Am
Geriatr Soc 1990; 38: 1093–6.
17. Bootsma-van der Wiel A, Gussekloo J, De Craen AJ et al
Disability in the oldest old: ‘can do’ or ‘do do’? J Am Geriatr
Soc 2001; 49: 909–14.
18. Kempen GI, Miedema I, Ormel J, Molenaar W. The assess-
ment of disability with the Groningen Activity Restriction
Scale. Conceptual framework and psychometric properties.
Soc Sci Med 1996; 43: 1601–10.
19. Izaks GJ, Gussekloo J, Dermout KM, Heeren TJ, Ligthart
GJ. Three-year follow-up of mini-mental state examination
score in community residents aged 85 and over. Psychol Med
1995; 25: 841–8.
20. Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM.
Association of comorbidity with disability in older women:
the Women’s Health and Aging Study. J Clin Epidemiol
1999; 52: 27–37.
21. Oeppen J, Vaupel JW. Demography. Broken limits to life
expectancy. Science 2002; 296: 1029–31.
22. Hoogerduijn JG, Schuurmans MJ, Duijnstee MS, de Rooij
SEGrypdonck MF. A systematic review of predictors and
screening instruments to identify older hospitalized patients
at risk for functional decline. J Clin Nurs 2007; 16: 46–57.
23. Winblad I, Jaaskelainen M, Kivela SL, Hiltunen P, Laippala P.
Prevalence of disability in three birth cohorts at old age over
time spans of 10 and 20 years. J Clin Epidemiol 2001; 54:
1019–24.
Received 4 October 2010; accepted in revised form
25 November 2010
357
Disability, cognition and multimorbidity